Novo Nordisk A/S (NYSE:NVO)

100.39
Delayed Data
As of Dec 01
 -1.45 / -1.42%
Today’s Change
62.41
Today|||52-Week Range
105.69
+48.35%
Year-to-Date
Is Eli Lilly a Better Stock to Buy and Hold Over the Next 10 Years Than Novo Nordisk?
5:53am / MotleyFool.com - Paid Partner Content
Could Ozempic Harm These 3 Medical Device Stocks?
Nov 25 / MotleyFool.com - Paid Partner Content
Market Today: Coinbase Surges Amid Bitcoin Rally, Gold Hits Record High
Dec 01 / GuruFocus News - Paid Partner Content
Here's Why Investors Should Hold Encompass Health (EHC) Now
Nov 24 / Zacks.com - Paid Partner Content
Will Novo Nordisk Be a Trillion-Dollar Stock by 2030?
Dec 01 / MotleyFool.com - Paid Partner Content
Top Stock Reports for Eli Lilly, Accenture & The TJX Companies
Nov 24 / Zacks.com - Paid Partner Content
FDA Accepts Karuna's (KRTX) NDA Filing for Schizophrenia Drug
Nov 30 / Zacks.com - Paid Partner Content
Novo Nordisk (NVO) to Expand Manufacturing Site in France
Nov 24 / Zacks.com - Paid Partner Content
Is it a Good Idea to Invest in Harpoon (HARP) Stock Now?
Nov 30 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: NVO & LLY to Expand Manufacturing Capacity in Europe, & More
Nov 24 / Zacks.com - Paid Partner Content
Eli Lilly's Weight-Management Drug Outperformed Ozempic. Is It Time to Buy?
Nov 30 / MotleyFool.com - Paid Partner Content
New Strong Buy Stocks for November 24th
Nov 24 / Zacks.com - Paid Partner Content
Vanguard Health Care Fund's Strategic Moves: Spotlight on Ono Pharmaceutical Co Ltd
Nov 29 / GuruFocus News - Paid Partner Content
$3,000 Invested in These 3 Top Stocks Could Make You Rich in 10 Years
Nov 23 / MotleyFool.com - Paid Partner Content
Emergent (EBS) Gets $75M BARDA Contract for Anthrax Vaccine
Nov 29 / Zacks.com - Paid Partner Content
Eli Lilly (LLY) Stock Outperforms Industry YTD: Here's Why
Nov 23 / Zacks.com - Paid Partner Content
Is Alpine Immune Sciences (ALPN) Outperforming Other Medical Stocks This Year?
Nov 29 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights Novo Nordisk Bank of America, Netflix, Johnson & Johnson and TotalEnergies
Nov 22 / Zacks.com - Paid Partner Content
Merck's (MRK) Pneumococcal Jab Shows Upbeat Responses in Study
Nov 29 / Zacks.com - Paid Partner Content
Merck (MRK) to Acquire Private Neuroscience Company for $610M
Nov 22 / Zacks.com - Paid Partner Content
Ozempic Receives Some Very Bad News: Is It Time to Sell Novo Nordisk Stock?
Nov 29 / MotleyFool.com - Paid Partner Content
Here's How Much You'd Have If You Invested $1000 in Novo Nordisk a Decade Ago
Nov 22 / Zacks.com - Paid Partner Content
AbbVie (ABBV) Lymphoma Drug Gets FDA Breakthrough Therapy Tag
Nov 28 / Zacks.com - Paid Partner Content
Top Analyst Reports for Novo Nordisk, Bank of America & Netflix
Nov 21 / Zacks.com - Paid Partner Content
3 Large Drug Stocks That Have Outperformed Industry YTD
Nov 28 / Zacks.com - Paid Partner Content
J&J (JNJ) Seeks Expanded Use of Lung Cancer Drug Rybrevant
Nov 21 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights Gartner, The Progressive, InterContinental Hotels, Cboe Global Markets and Novo Nordisk
Nov 28 / Zacks.com - Paid Partner Content
Is Novo Nordisk (NVO) a Buy as Wall Street Analysts Look Optimistic?
Nov 21 / Zacks.com - Paid Partner Content
5 Must-Buy Stocks at 52-Week High With More Upside for 2024
Nov 27 / Zacks.com - Paid Partner Content
Lilly (LLY) to Build $2.5B Plant to Meet Increased Drug Demand
Nov 20 / Zacks.com - Paid Partner Content
Beat the Market Like Zacks: UnitedHealth, Casey's, Cencora in Focus
Nov 27 / Zacks.com - Paid Partner Content
Ozempic Might Be Helping Abbott Laboratories and DexCom Stock. Here's How.
Nov 20 / MotleyFool.com - Paid Partner Content
4 Must-Buy Profitable Stocks Using Net Income Ratio
Nov 27 / Zacks.com - Paid Partner Content
3 Stock-Split Stocks Billionaires Are Buying Hand Over Fist
Nov 20 / MotleyFool.com - Paid Partner Content
The Zacks Analyst Blog Highlights Eli Lilly, Accenture, TJX, Novo Nordisk and Salesforce
Nov 27 / Zacks.com - Paid Partner Content
Eli Lilly Just Got One Step Closer to Dethroning Ozempic. Time to Buy the Stock?
Nov 19 / MotleyFool.com - Paid Partner Content
Is Pfizer Stock a Buy Ahead of This Highly Anticipated Weight Loss Readout?
Nov 26 / MotleyFool.com - Paid Partner Content